Laboratory Interpretation: Hemoglobin 12.0 g/dL, MCH 32.3 pg, MPV 8.6 fL
These laboratory values indicate mild anemia with normal red cell indices and normal platelet size, requiring a complete diagnostic workup to identify the underlying cause, with particular attention to iron studies, vitamin B12/folate levels, and reticulocyte count. 1, 2
Anemia Classification
This hemoglobin of 12.0 g/dL meets criteria for anemia in most populations:
- In adult males and postmenopausal females, anemia is defined as Hgb <12 g/dL, making this a borderline value requiring investigation 1
- In premenopausal females, this Hgb of 12.0 g/dL is at the lower limit of normal (anemia defined as <11 g/dL in this population) 1
- The World Health Organization defines anemia as Hgb <13.0 g/dL in men and <12.0 g/dL in women, placing this value at the threshold 3
- This represents mild anemia (Hgb ≥10 g/dL and ≤11.9 g/dL) if the patient is male or postmenopausal female 1
Red Cell Indices Analysis
The MCH of 32.3 pg is within normal range (27-33 pg), indicating normochromic red cells:
- Normal MCH effectively rules out iron deficiency anemia as the primary cause, as MCH has the highest correlation with hemoglobin among red cell indices and identifies 97-100% of anemic iron-deficient individuals when low 4
- The anemia is normocytic-normochromic, which suggests chronic disease, early nutritional deficiency, chronic kidney disease, or bone marrow dysfunction rather than iron deficiency 1
- Low MCV and MCH typically indicate iron deficiency, vitamin B12/folate deficiency, or hemoglobinopathies, none of which are suggested by this normal MCH 1
Platelet Parameters
The MPV of 8.6 fL is within normal range (7.5-11.5 fL), indicating normal platelet production:
- Normal MPV with presumably normal platelet count suggests no primary platelet disorder or bone marrow dysfunction affecting megakaryocyte lineage 5
- High MPV would suggest hyperdestructive causes, myeloproliferative disorders, or thalassemia 5
- Low MPV would indicate cytotoxic drug effects, marrow hypoplasia, sepsis, or splenomegaly 5
Required Diagnostic Workup
The following tests must be obtained to determine the cause of this mild normocytic anemia:
Essential Initial Tests 2
- Complete blood count with differential to assess all three cell lines (abnormalities in two or more cell lines warrant hematology consultation) 1
- Absolute reticulocyte count to determine if bone marrow response is appropriate (low/normal suggests impaired erythropoiesis; elevated suggests hemolysis or blood loss) 1, 2
- Serum ferritin (most useful marker for iron stores; <30 μg/L confirms iron deficiency in absence of inflammation) 2
- Transferrin saturation (TSAT) (<15-16% supports iron deficiency and is less affected by inflammation than ferritin) 1, 2
- Vitamin B12 and folate levels (essential for evaluating any anemia, even when normocytic) 1, 2
- Renal function tests (creatinine, eGFR) to assess for chronic kidney disease as a cause 1
Additional Tests Based on Clinical Context 2
- Haptoglobin, LDH, and indirect bilirubin if hemolysis is suspected 2
- Direct antiglobulin test (Coombs) for patients with chronic lymphocytic leukemia, non-Hodgkin lymphoma, or autoimmune disease history 1, 2
- TSH when clinically indicated 2
- Hemoglobin electrophoresis if thalassemia trait suspected based on ethnicity 2
- C-reactive protein to assess for inflammation/chronic disease 1
Clinical Context Considerations
The interpretation depends critically on patient demographics and clinical setting:
- In chronic kidney disease patients, anemia workup should be initiated when Hgb falls to <12 g/dL in adult males/postmenopausal females or <11 g/dL in premenopausal females 1
- In elderly patients, mild anemia (10-12 g/dL) is common, with one-third due to nutritional deficiency, one-third to chronic disease, and one-third unexplained 3
- In cancer patients on chemotherapy, this Hgb of 12.0 g/dL would not typically warrant erythropoiesis-stimulating agents (ESAs are considered only when Hgb ≤10 g/dL) 1
- Gastrointestinal evaluation is mandatory in adult men and postmenopausal women with confirmed iron deficiency, as GI blood loss is the most common cause 1
Critical Pitfalls to Avoid
- Do not accept ferritin alone in patients with inflammation or chronic disease; always use TSAT to confirm iron deficiency, as ferritin is an acute-phase reactant 1, 2
- Do not assume dietary insufficiency without complete investigation, even in patients with borderline deficient diets 2
- Do not stop investigation after finding one GI lesion; dual pathology (upper and lower GI tract lesions) occurs in 10-15% of patients 1, 2
- Do not delay hematology consultation when abnormalities in two or more cell lines are present 1, 2
- Hemoglobin is preferred over hematocrit for monitoring because it is more reproducible across laboratories and unaffected by sample storage time or glucose levels 1